Cosmos Holdings Inc.
COSM • NASDAQ
Cosmos Holdings Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Grigorios Siokas, with a market cap of $16.4M.
CEOGrigorios Siokas
Market Cap$16.4M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees102.0
Websitecosmoshold.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cosmos Holdings Inc.
Date
Wednesday, April 15, 2026 (in 2 months)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.04
Revenue Estimate
$18.8M
Earnings History
Past 12 earnings reports for Cosmos Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$0.02 | — | $17.1M | — |  10-Q |
| Aug 18, 2025 | Q2 2025 | -$0.10 | — | $14.7M | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.03 | — | $13.7M | — | 10-Q |
| Apr 16, 2025 | Q4 2024 | -$0.45Est: -$0.11 | -309.1% | $14.2MEst: $14.5M | -1.9% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.45Est: -$0.11 | -309.1% | $12.4MEst: $14.5M | -14.4% | 10-Q |
| Aug 19, 2024 | Q1 2024 | -$0.11Est: -$0.14 | +21.4% | $14.6MEst: $14.6M | +0.2% | 10-Q |
| Aug 6, 2024 | Q4 2023 | -$1.73Est: -$0.20 | -765.0% | $15.8MEst: $13.8M | +15.2% | 10-K |
| Nov 20, 2023 | Q3 2023 | -$0.27 | — | $12.8M | — | — |
| Aug 15, 2023 | Q2 2023 | $0.01 | — | $12.4M | — | 10-Q |
| May 16, 2023 | Q1 2023 | -$0.04 | — | $12.3M | — | 10-Q |
| Apr 12, 2023 | Q4 2022 | $11.09 | — | $12.1M | — | — |
| Nov 14, 2022 | Q3 2022 | -$2.00 | — | $12.0M | — | — |